BUZZ-Sinclair Pharma: surges as possible sale considered

** Sinclair IS Pharma Plc's shares rise as much as12.4 pct after saying it is evaluating options, including apossible sale.

** Sinclair's shares hit 3-1/2-yr high and among top pctgainers on LSE. Volume busy at 1.27x the 30-day avg in earlytrade.

** Dermatology and skin care company appoints Rothschild toassist it in evaluating options and says Chairman Grahame Cookwill announce strategic review and commencement of offer periodto shareholders at the company's annual general meeting later onTuesday.

** N+1 Singer says while Sinclair's portfolio could "bringsubstantial value to a potential acquirer".

** N+1 Singer keeps "buy" rating on the stock. Out of the 7analysts covering Sinclair, 6 have "strong buy" or "buy" rating,according to Thomson Reuters data.